New federal regulations governing the Patented Medicine Prices Review Board (PMPRB) and the regulation of drug prices will come into effect in six months’ time (on January 1, 2021). These changes have been very controversial. The PMPRB has just released its proposed guidelines to implement the new regulations and is now consulting on them with stakeholders and the public.
- Join CCSN and our presenters, Wayne Critchley from Global Public Affairs and Ryan Clarke from Advocacy Solutions, to learn more about:
- The new drug pricing rules.
- The expected impact of the latest changes and implications for cancer patients.
- Guidance to support the cancer community’s engagement at this stage of regulatory reform.